Merkel cell polyomavirus DNA in CSF of paediatric patients with suspected meningitis or encephalitis.
- 1Department of Microbiology and Immunology, University of Tehran, Tehran, Iran.
- 2Valiasr Hospital, Imam Khomeini Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
- 3Department of Microbiology and Immunology, University of Tehran, Tehran, Iran. [email protected].
Abstract
Background
The clinical significance of Merkel cell polyomavirus (MCPyV) in pediatric central nervous system (CNS) infections remains uncertain, particularly in immunocompromised children.Objective
To determine the frequency of MCPyV DNA in cerebrospinal fluid (CSF) from children with suspected viral meningitis or encephalitis and evaluate its association with HIV infection, CSF findings, and clinical outcomes.Methods
CSF samples from 46 pediatric patients with suspected viral CNS infection were analyzed using TaqMan probe-based quantitative PCR targeting the large T-antigen gene. Positive specimens were confirmed by amplification of an independent VP1 target and bidirectional Sanger sequencing following conventional PCR re-amplification. Clinical, laboratory, and outcome data were compared using appropriate statistical tests.Results
MCPyV DNA was detected in 6/46 patients (13.0%), all of whom were HIV-positive (p = 0.001; sensitivity analysis excluding patients with unknown HIV status, p = 0.002). Four isolates belonged to genotype I and two to genotype IIc. Compared with MCPyV-negative patients, MCPyV-positive patients had higher CSF lymphocyte percentages (89% vs. 84%; p = 0.048), higher protein concentrations (79 vs. 68 mg/dL; p = 0.022), lower glucose concentrations (51 vs. 55 mg/dL; p = 0.038), and more frequent altered consciousness (83.3% vs. 37.5%; p = 0.039). EBV DNA co-detection was identified in one MCPyV-positive patient.Conclusions
MCPyV DNA was detected exclusively in HIV-positive children and was associated with inflammatory CSF abnormalities. These findings suggest a possible association between MCPyV detection, immunosuppression, and CNS inflammation but do not establish causality. Larger multicenter studies are required.
Related
- Case Report: Late-onset BK polyomavirus-associated nephropathy with encephalitis, antibody-mediated rejection, and atypical hemolytic uremic syndrome: a rare overlap causing allograft dysfunction, therapeutic challenges, and multidisciplinary management
- Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1—viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT
- Meningitis, encephalitis, and beyond: A practical intensive care unit guide to severe central nervous system infections.
- Genetic diversity and low-level infection of Malawi polyomavirus in pediatric patients in Brazil
- A neuropsychiatric presentation of suspected immune-mediatedneuropathy: diagnostic overlap between Guillain–Barré syndrome andautoimmune encephalitis—a case
BibTeX
@article{hemmati2026merkel,
title = {{Merkel cell polyomavirus DNA in CSF of paediatric patients with suspected meningitis or encephalitis.}},
author = {Negar Hemmati and Fatemeh Hoda Fallah and Bahman Abedi Kiasari},
journal = {Virology journal},
year = {2026},
month = jul,
doi = {10.1186/s12985-026-03261-8},
url = {https://europepmc.org/article/MED/42902299},
note = {CC BY},
}
RIS
TY - JOUR
TI - Merkel cell polyomavirus DNA in CSF of paediatric patients with suspected meningitis or encephalitis.
AU - Negar Hemmati
AU - Fatemeh Hoda Fallah
AU - Bahman Abedi Kiasari
PY - 2026
DA - 2026/07/01
JO - Virology journal
DO - 10.1186/s12985-026-03261-8
UR - https://europepmc.org/article/MED/42902299
AB - Background The clinical significance of Merkel cell polyomavirus (MCPyV) in pediatric central nervous system (CNS) infections remains uncertain, particularly in immunocompromised children.Objective To determine the frequency of MCPyV DNA in cerebrospinal fluid (CSF) from children with suspected viral meningitis or encephalitis and evaluate its association with HIV infection, CSF findings, and clinical outcomes.Methods CSF samples from 46 pediatric patients with suspected viral CNS infection were analyzed using TaqMan probe-based quantitative PCR targeting the large T-antigen gene. Positive specimens were confirmed by amplification of an independent VP1 target and bidirectional Sanger sequencing following conventional PCR re-amplification. Clinical, laboratory, and outcome data were compared using appropriate statistical tests.Results MCPyV DNA was detected in 6/46 patients (13.0%), all of whom were HIV-positive (p = 0.001; sensitivity analysis excluding patients with unknown HIV status, p = 0.002). Four isolates belonged to genotype I and two to genotype IIc. Compared with MCPyV-negative patients, MCPyV-positive patients had higher CSF lymphocyte percentages (89% vs. 84%; p = 0.048), higher protein concentrations (79 vs. 68 mg/dL; p = 0.022), lower glucose concentrations (51 vs. 55 mg/dL; p = 0.038), and more frequent altered consciousness (83.3% vs. 37.5%; p = 0.039). EBV DNA co-detection was identified in one MCPyV-positive patient.Conclusions MCPyV DNA was detected exclusively in HIV-positive children and was associated with inflammatory CSF abnormalities. These findings suggest a possible association between MCPyV detection, immunosuppression, and CNS inflammation but do not establish causality. Larger multicenter studies are required.
SN - 1743-422X
ER -